Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04510376 · ClinicalTrials.gov registry record · NA
Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method
A NA study, sponsored by Omeza.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04510376 is a NA study that has completed, run by Omeza. The registered enrollment target is 25 participants.
The verdict
NCT04510376, a NA study, has completed, sponsored by Omeza.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects
Interventions
- OTHER Negative Control
- OTHER Positive Control
- DEVICE Test Article
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-11-14 |
| Est. Completion | 2019-11-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04510376
The ClinicalTrials.gov registry entry for NCT04510376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Omeza, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Negative Control is the first listed.
NCT04510376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04510376 about?
NCT04510376 is a clinical study titled "Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method". Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects
What is the current status of trial NCT04510376?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-11-14. Estimated completion is 2019-11-14.
What interventions are being tested in trial NCT04510376?
The interventions under investigation include: Negative Control (OTHER), Positive Control (OTHER), Test Article (DEVICE).
Who is sponsoring clinical trial NCT04510376?
This trial is sponsored by Omeza, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.